Wissam Jaber, MD
Pulmonary Disease · Atlanta, GANPI 1396922878
Payments from drug & device makers
Across 80 payments — averaging $194.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$4K
- Inquis Medical, Inc.$4K
- Penumbra, Inc.$2K
- Boston Scientific$1K
- Veran Medical Technologies, Inc.$736
- Inari Medical, Inc.$692
- plus $2K from 11 others
What the payments were for
- Consulting fees$4,00035%
- Speaking & faculty fees$2,20019%
- Travel & lodging$7977%
- Food & beverage$4,29838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 4 | $4,290 |
| Inquis Medical, Inc. | 2 | $4,120 |
| Penumbra, Inc. | 1 | $2,200 |
| Boston Scientific | 31 | $1,111 |
| Veran Medical Technologies, Inc. | 3 | $736 |
| Inari Medical, Inc. | 6 | $692 |
| Medtronic(2 entities) | 9 | $598 |
| Abbott | 8 | $541 |
| Teleflex LLC | 3 | $348 |
| Asahi Intecc USA, Inc. | 3 | $278 |
| Shockwave Medical, Inc | 2 | $163 |
| Edwards Lifesciences | 1 | $161 |
| Abiomed | 1 | $123 |
| Verge Medical, Inc. | 1 | $88 |
| Endovascular Engineering Inc. | 2 | $79 |
| Intuitive Surgical | 2 | $44 |
| Cardiva Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aventus$4,120
- Indigo System$2,200
- Spin$736
- FLOWTRIEVER CATHETER, S$539
- CT THROMBECTOMY SYSTEM KIT$539
- Xience V coronary stent system$425
- ONYX FRONTIER$295
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$161
- ASAHI PTCA Guide Wire$159
- RAIDER$140
- Vascular Lithotripsy$138
- RESOLUTE ONYX$128
- Impella$123
- FlowTriever$122
- ClotTriever$122
- ROTAPRO$117
- TURNPIKE$113
- COMET$108
How this compares
$15,585 in reported general payments places this provider in the 75th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 36 | $23,004 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $13,095 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $5,438 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $3,064 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,541 |
| Azithromycin | 26 | $272 |
| Levocetirizine Dihydrochloride | 12 | $190 |
| Fluticasone Propionate | 15 | $126 |
| Prednisone | 18 | $38 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Atlanta
- Srihari VeeraraghavanAtlanta$1.3M
- Micah FisherAtlanta$1.2M
- Frances LeeAtlanta$1.2M
- Colin SwensonAtlanta$777K
- Paul BoyceAtlanta$406K
- Ishan MehtaAtlanta$198K
- Seth WalkerAtlanta$189K
- Annette EsperAtlanta$186K
- Avanthika WynnAtlanta$181K
- David BerkowitzAtlanta$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.